Table 3 McNemar test for preintervention and postintervention process and patient outcome measures.
| Variable | No change below target (n) | No change at target (n) | Change: at target to below (n) | Change: below target to at target (n) | McNemar test (p value) |
|---|---|---|---|---|---|
| Diabetes process measure | |||||
| A1c within 3 months | 19 | 188 | 28 | 42 | 0.0943 |
| BP within 3 months | 2 | 264 | 7 | 4 | 0.3657 |
| LDL within 12 months | 20 | 213 | 16 | 28 | 0.0704 |
| MiAL within 12 months | 51 | 149 | 18 | 59 | <0.001 |
| LEAP within 12 months | 76 | 148 | 11 | 42 | <0.001 |
| Patient outcome measure | |||||
| A1c <7.0 | 157 | 53 | 40 | 53 | 0.1122 |
| BP <130/80 | 106 | 62 | 56 | 53 | 0.7738 |
| LDL <100 | 167 | 110 | 0 | 0 | — |
| MiAL <30 | 113 | 95 | 23 | 46 | 0.0056 |
| LEAP score 0 | 86 | 143 | 13 | 35 | 0.0015 |
A1c, blood sugar level; BP, blood pressure; LDL, low‐density lipoprotein; LEAP, lower extremity amputation prevention; MiAL, microalbumin.